Levetiracetam

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  (s)-2-(2-oxopyrrolidin-1-yl)butanamide;(S)-1-pyrrolidineacetamid;(+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;1-Pyrrolidineacetamide;alpha-ethyl-2-oxo-;alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;Etiracetamum [INN-Latin];Keppra;Levetiracetam [INN];Levetiracetamum [INN-Latin];LEVITIRACETAM;UCB 6474;UCB-6474;UCB-L 059;Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam);(2R)-2-(2-oxopyrrolidin-1-yl)butanamide;(2S)-2-(2-oxopyrrolidin-1-yl)butanamide;Levetiracetame;

• CAS NO :

  102767-28-2

• EC NO :

• Molecular Formula :

  C₈H₁₄N₂O₂

• Molecular Weight :

  170.209

• Main Specifications :

  IHS

• InChI :

  InChI=1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1

• Product description :

  [Generic Name]： Levetiracetam [Chemical Name]： (aS)-a-ethyl-2-oxo-1-pyrrolidineacetamide [CAS No.]： [102767-28-2] [Molecular Formula]： C8H14N2O2 [Molecular Weight]： 170.10 ［Specification］： Enterprises standard ［Appearance］： White crystalline powder ［Melting point］： 115-118℃ ［Loss on Drying］： ≤0.5% ［Heavy metals］： ≤20ppm ［Specific Optical Rotation］： -86~-91o ［Assay］： ≥99% ［Use］： Antiepileptic

• Uses :

  Antiepileptic

• Molecular Structure :